<DOC>
	<DOCNO>NCT01208155</DOCNO>
	<brief_summary>Study healthy male assess bioavailability 4 different fostamatinib tablet</brief_summary>
	<brief_title>Study Healthy Males Assess Bioavailability 4 Different Fostamatinib Tablets</brief_title>
	<detailed_description />
	<criteria>Weight least 50 kg body mass index ( BMI ) 18.0 35.0 kg/m2 inclusive Volunteers must willing use barrier contraception ie , condom , Day 1 Treatment Period 1 2 week final dose investigational product ( IP ) History clinically significant disease disorder History presence GI , hepatic , renal disease condition know interfere absorption , distribution , metabolism , excretion drug ( except cholecystectomy ) Any clinically significant illness , medical/surgical procedure trauma within 4 week first administration drug Volunteers smoke 5 cigarette equivalent tobacco per day Any clinically significant abnormality clinical chemistry , hematology urinalysis result judge Investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Healthy</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Fostamatinib</keyword>
</DOC>